News
Après plusieurs années à soigner et accompagner des personnes, nombreux sont les professionnels de santé qui souhaitent ...
This release has been authorised by the directors of Immuron Limited. Steven Lydeamore Chief Executive Officer ...
Dogecoin Cash Inc. has established a wholly owned subsidiary, Dogecoin Treasury, Inc. (DTI), which is intended to accumulate DOGE through direct acquisition, mining operations, and other potential ...
The Company intends to use the net proceeds for commercialization efforts, including expanding coverage and improving patient access, global clinical development to advance the core pipeline ...
À propos de l’EAACI L’Académie européenne d’allergologie et d’immunologie clinique (EAACI) est la plus grande association professionnelle européenne de ces domaines thérapeutiques. Elle s’engage à ...
Mukul Mehta, currently Head of Business Planning and Analysis (BPA), Digital Finance and Tax, has been appointed Chief Financial Officer, effective March 16, 2026, and will join the Executive ...
Leiden, the Netherlands, July 17, 2025: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms that it will report its preliminary (unaudited) financial results for the ...
The boards of directors of both Voyager and VERAXA unanimously approved the Business Combination. Voyager and VERAXA expect the Business Combination to close in the fourth quarter of 2025. The ...
Q2 net sales grew +11% (cc 1, +12% USD) with core operating income 1 up +21% (cc, +20% USD) Sales growth driven by continued strong per ...
Paris, le 17 juillet 2025. Sanofi annonce aujourd'hui que Rothko Merger Sub, Inc., une filiale détenue à 100 % par Sanofi, a prolongé la date d'expiration de son offre publique d'achat qui vise à acqu ...
This year’s Congress was a turning point,” said Prof. Maria Torres, EAACI President. “We are entering an era where scientific innovation, equity in care, and environmental health must move forward ...
Sanofi announces extension of Blueprint tender offer. Paris, July 17, 2025. Sanofi today announces that Rothko Merger Sub, Inc., a wholly owned subsidiary of Sanofi, has extended ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results